Westin Miyako Kyoto Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

This meeting took place in 2015


Here are the related meetings in 2017:
Diabetes (J3)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Diabetes: New Insights into Molecular Mechanisms and Therapeutic Strategies (T2)


Organizer(s) Takashi Kadowaki, Juleen R. Zierath, Nobuya Inagaki and Barbara B. Kahn
October 25—29, 2015
Westin Miyako Kyoto • Kyoto, Japan
Discounted Abstract Deadline: Jun 25, 2015
Abstract Deadline: Jul 23, 2015
Scholarship Deadline: Jun 25, 2015
Discounted Registration Deadline: Aug 25, 2015

Lead Sponsor: Takeda Pharmaceutical Company Ltd. Other Sponsors: Astellas Pharma Inc., Journal of Molecular Cell Biology (JMCB), Novo Nordisk A/S and Sanofi-Aventis Deutschland GmbH

Summary of Meeting:
The prevalence of type 2 diabetes is rising to epidemic proportions worldwide. Type 2 diabetes is a complex disease caused by dysfunction of multiple organ systems, and disease susceptibility is profoundly influenced by both genetic and environmental factors. It is essential to bring leading professionals in the academic and pharmaceutical communities together with various specialties in diabetes research to share new approaches and research paradigms. The meeting will present the latest discoveries in diabetes research, highlighting essential aspects of diabetes, as well as emerging themes that are likely to provide novel therapeutic approaches. The major topics of the meetings are: Islet Dysfunction; Gut Biology and Systemic Metabolism; CNS Control of Metabolism; Adipocyte Biology; Insulin Resistance; Genetics and Epigenetics; Diabetes and Healthy Lifespan and Regenerative Medicine. The ultimate goal for the meeting is to provide a forum that encourages attendees to communicate and exchange ideas to facilitate an integrative understanding of pathogenesis and development of therapeutic strategies for prevention and treatment of diabetes.

View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Sunday, October 25 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, October 29 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Friday, October 30 in order to fully experience the meeting.

SUNDAY, OCTOBER 25

16:00—20:00
Arrival and Registration

Mizuho Foyer
18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Mizuho Foyer

MONDAY, OCTOBER 26

07:30—08:30
Breakfast

Mizuho A
08:00—08:30
Poster Setup

Mizuho A
08:30—17:00
Poster Viewing

Mizuho A
08:30—08:40
Welcome Remarks
Meeting has ended...abstracts no longer viewable online.

Takashi Kadowaki, University of Tokyo, Japan

08:40—11:30
Islet Dysfunction in Diabetes
Meeting has ended...abstracts no longer viewable online.

Mizuho B
* Domenico Accili, Columbia University, USA

* Markus Stoffel, ETH Zürich, Switzerland
MicroRNA Function in Pancreatic beta-Cells

Roland W. Stein, Vanderbilt University Medical Center, USA
Identification and Characterization of Transcriptional Coregulators of MafA and Pdx1

Nobuya Inagaki, Kyoto University Graduate School of Medicine, Japan
Non-Invasive Pancreatic Beta-Cell Imaging Using Radiolabeled Exendin Probe

Nadeeja T. Wijesekara, University of Toronto, Canada
Short Talk: Amyloid beta Induced Insulin Resistance Leads to Diabetes and Severe Neurodegeneration in Transgenic Mice

Andrew Parker, GeNeuro SA, Switzerland
Short Talk: Human Endogenous Retrovirus Type W Is Strongly Upregulated in T1D Pancreas and Dysregulates Insulin Production in vitro and in vivo

C.K. Wong, University of British Columbia, Canada
Short Talk: p300 Regulates Glucose Homeostasis by Maintaining Islet Mass

09:50—10:10
Coffee Break

Mizuho Foyer
11:30—12:15
Lunch

Mizuho A
12:00—14:00
Poster Session 1

Mizuho A
14:00—16:00
Workshop 1: Islet, Brain and Gut Biology

Mizuho B
* Bei B. Zhang, Lilly China Research and Development Co., Ltd., China

* Hisamitsu Ishihara, Nihon University School of Medicine, Japan

Yau-Sheng Tsai, National Cheng Kung University, Taiwan
Egr-1 Deficiency Sensitizes Pancreatic beta-Cells to Palmitate-Induced ER Stress and Apoptosis

Eitan M. Akirav, Winthrop University Hospital, USA
Demethylating Cytosine Analogs Reverse T1D and Improve beta-Cell Function

Yuichi Tsuchiya, Nara Institute of Science and Technology, Japan
Physiological Activation of IRE1a Upregulates a Subset of Insulin Folding Enzymes in Pancreatic b Cells

Yasuhiko Minokoshi, National Institute for Physiological Sciences, Japan
AMP-Activated Protein Kinase in CRH Neurons in the PVH Controls Food Selection Behavior

Hua V. Lin, Eli Lilly & Co., USA
Stimulation of Insulin and Incretin Secretion by Tryptophan Is Mediated by GPR142

Olga Rudenko, Copenhagen University, Denmark
Agonists for the Aromatic Amino Acid Receptor GPR142 Provides a Broad, Balanced Stimulation of Pancreatic and Gut Hormones Strongly Stimulating Glucose Disposal

16:00—16:15
Coffee Available

Mizuho Foyer
16:15—17:15
Keynote Address
Meeting has ended...abstracts no longer viewable online.

Mizuho B
* Nobuya Inagaki, Kyoto University Graduate School of Medicine, Japan

Shinya Yamanaka, Center for iPS Cell Research and Application, Kyoto University, Gladstone Institutes, Japan
Recent Progress in iPS Cell Research toward Regenerative Medicine

17:15—19:15
Regenerative Medicine in Diabetes
Meeting has ended...abstracts no longer viewable online.

Mizuho B
* Kohjiro Ueki, University of Tokyo, Graduate School of Medicine, Japan

Domenico Accili, Columbia University, USA
The New Biology of Beta Cell Failure

Laura C. Alonso, University of Massachusetts Medical School, USA
Homeostatic Control of beta Cell Proliferation by Insulin Demand via the Unfolded Protein response

* James M. Wells, Cincinnati Children's Hospital Research Foundation, USA
Human Pluripotent Stem Cell-derived Tissues as New Models to Study Development, Digestive Diseases and Diabetes

Noriko Kodani, Keio University, Japan
Short Talk: Foxo1 CoRepressor (FCoR) Regulates alpha-Cell Mass and Maintain beta-Cell Identity in Cooperation with Foxo1

19:00
On Own for Dinner


TUESDAY, OCTOBER 27

07:30—08:30
Breakfast

Mizuho A
08:30—11:45
CNS Control of Metabolism
Meeting has ended...abstracts no longer viewable online.

Mizuho B
* Yasuhiko Minokoshi, National Institute for Physiological Sciences, Japan

Jens C. Brüning, Max Planck Institute for Metabolism Research, Germany
CNS-dependent Control of Metabolism

* Joel K. Elmquist, University of Texas Southwestern Medical Center, USA
SF-1 in the Hypothalamus: A Molecular Link Between Energy Balance Regulation and Exercise

Michael Krashes, NIDDK, National Institutes of Health, USA
A neural basis for melanocortin-4 receptor regulated appetite

Scott M. Sternson, HHMI/Janelia Research Campus, USA
Molecular and Systems Neuroscience of Weight Loss

Stephanie M. Correa, University of California, San Francisco, USA
Short Talk: Sex-Specific Metabolic Roles of Estrogen Receptor alpha Signaling in the Mediobasal Hypothalamus

Lotte Bjerre Knudsen, Novo Nordisk A/S, Denmark
Short Talk: Acylated GLP-1 Receptor Agonists Effectively Lower Body Weight and Directly Access POMC/CART Neurons in the Mouse Hypothalamus

09:50—10:10
Coffee Break

Mizuho Foyer
11:45—13:00
Poster Setup

Mizuho A
13:00—22:00
Poster Viewing

Mizuho A
11:45—17:00
On Own for Lunch

16:30—17:00
Coffee Available

Mizuho Foyer
17:00—19:00
Gut Biology and Systemic Metabolism
Meeting has ended...abstracts no longer viewable online.

Mizuho B
Nathalie Delzenne, Université Catholique de Louvain, Belgium
Gut Microbiota as a Tool in the Nutritional Management of Metabolic Disorders and Inflammation.

* Yutaka Seino, Kansai Electric Power Medical Research Institute, Japan
Incretin-Based Therapies for Type 2 Diabetes: Focus on East Asian Perspectives and Hypoglycemia

* Daniel J. Drucker, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Canada
Mechanisms of Incretin Action-A Molecular Approach

Erina Joo, Graduate School of Medicine, Kyoto University, Japan
Short Talk: Inhibition of GIP Receptor Signaling in Adipose Tissue Reduces Insulin Resistance and Improves Hepatic Steatosis in High Fat Diet-Induced Obesity

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Mizuho A
19:30—22:00
Poster Session 2

Mizuho A

WEDNESDAY, OCTOBER 28

07:30—08:30
Breakfast

Mizuho A
08:30—11:30
Novel Insights into Adipocyte Biology
Meeting has ended...abstracts no longer viewable online.

Mizuho B
* Toshimasa Yamauchi, University of Tokyo, Japan

* Bruce M. Spiegelman, Harvard Medical School, USA
Transcriptional Control of Brown and Beige Fat: Toward a New Generation of Therapeutics

Yu-Hua Tseng, Joslin Diabetes Center/Harvard Medical School, USA
Functional and Clonal Analyses of Human Brown and White Fat Progenitors

Philipp E. Scherer, University of Texas Southwestern Medical Center, USA
Diabetes, Obesity and the Central Role of the Adipocyte in Maintaining Systemic Homeostasis

Naja Zenius Jespersen, Rigshospitalet, Denmark
Short Talk: Human Perirenal Fat Display a Location-Dependent Brown Fat Phenotype

Mary N. Teruel, Stanford University, USA
Short Talk: Controlling Low Rates of Adipogenesis through Noise, Ultra-High Feedback and Sensing Circadian Rhythms

Yuta Hiraike, Graduate School of Medicine, University of Tokyo, Japan
Short Talk: NFIA Controls the Brown Fat Gene Program by Co-Localizing with PPARgamma at Cell-Type-Specific Enhancers

Kei Sakamoto, Nestlé Institute of Health Sciences SA, Switzerland
Short Talk: Mechanism of Action of Metformin- Insights from an AMP-Insensitive FBP1 Knockin Mouse Model

09:50—10:10
Coffee Break

Mizuho Foyer
11:45—13:00
Poster Setup

Mizuho A
13:00—22:00
Poster Viewing

Mizuho A
11:30—17:00
On Own for Lunch

16:30—17:00
Coffee Available

Mizuho Foyer
17:00—19:00
Molecular Mechanisms Underlying Insulin Resistance
Meeting has ended...abstracts no longer viewable online.

Mizuho B
* Takashi Kadowaki, University of Tokyo, Japan

* Barbara B. Kahn, Beth Israel Deaconess Medical Center, Harvard Medical School, USA
Discovery of a Novel Class of Lipids with Anti-Diabetic and Anti-Inflammatory Effects

David E. James, University of Sydney, Australia
Molecular Mapping of Insulin Action and Insulin Resistance

Masato Kasuga, National Center for Global Health and Medicine, Japan
Insulin Signaling Network for Understanding Diabetes

Yun Sok Lee, University of California, San Diego, USA
Short Talk: Saturated Fatty Acids and Mitochondrial Dysfunction Initiates Inflammation and Insulin Resistance in Obesity

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Mizuho A
19:30—22:00
Poster Session 3

Mizuho A

THURSDAY, OCTOBER 29

07:30—08:30
Breakfast

Mizuho A
08:30—11:45
Genetics and Epigenetics of Diabetes
Meeting has ended...abstracts no longer viewable online.

Mizuho B
* Masato Kasuga, National Center for Global Health and Medicine, Japan

Linong Ji, Peking University People’s Hospital, China
Genetic Study and Management of Diabetes: Asian Perspective

Philippe Froguel, Imperial College of London, UK
The Genetic Link between Nutrients, the Gut Microbiome and Metabolism

* Juleen R. Zierath, Karolinska Institutet, Sweden
Exercise as a Medicine to Improve Insulin Sensitivity in Type 2 Diabetes

Marcelo Nobrega, University of Chicago, USA
Regulatory Variants and Metabolic Diseases

Koshi Hashimoto, Tokyo Medical and Dental University, Japan
Short Talk: DNA Methylation Status in Early Life as an Epigenetic Memory and Its Physiological Significance in Later Life

Yurong Xin, Regeneron Pharmaceuticals, Inc., USA
Short Talk: Single-cell RNA Sequencing of Healthy and Type 2 Diabetes Pancreatic Islet Cells

09:50—10:10
Coffee Break

Mizuho Foyer
11:45—14:30
On Own for Lunch

14:30—16:30
Workshop 2: Insulin Resistance, Healthy Lifespan and Genetics of Diabetes

Mizuho B
* Yu-Hua Tseng, Joslin Diabetes Center/Harvard Medical School, USA

* Iichiro Shimomura, Osaka University Graduate School of Medicine, Japan

Guang Yang, University of Sydney, Australia
Characterization of RagC Phosphorylation Sites Reveals Self-Regulation of mTOR Complex 1

Natasha Chaudhary, Weill Cornell Medical College, USA
RAB22A, a Regulator of Menkes Copper Transporter ATP7A Trafficking, Functions in Insulin-Stimulated GLUT4 Trafficking

Tetsuya Kimura, Immunology Frontier Research Center, Osaka University, Japan
Prevention of Obesity, Fatty Liver and Diabetes by Macrophages

Sang Won Park, Boston Childrens Hospital, USA
Regulation of Glucose Homeostasis through brd7-p85 Interaction

Essi M. Havula, University of Helsinki and Institute of Biotechnology, Finland
ChREBP/Mondo-Mlx Mediates Organismal Sugar sensing through Gli-Similar Transcription Factor Sugarbabe

Markus Jabs, German Cancer Research Center, Germany
The Endothelium Actively Balances Glucose and Fatty Acid Metabolism

Yibo Wu, Institute of Molecular Systems Biology, ETH Zurich, Switzerland
Systems Proteomics and Trans Omic Data Integration – Uncovering Novel Diabetic Genes

16:30—17:00
Coffee Available

Mizuho Foyer
17:00—18:45
Diabetes and Healthy Lifespan
Meeting has ended...abstracts no longer viewable online.

Mizuho B
* Philippe Froguel, Imperial College of London, UK

* Masaomi Nangaku, University of Tokyo School of Medicine, Japan

Ulf Smith, Göteborg University, UGOT, Sweden
The Roles of Wnt and BMP Signaling in Insulin Resistance and Obesity

Gary Krishnan, Eli Lilly and Company, USA
Efficient Remodeling of Skeletal Muscle Is Crucial for Recovery after Exercise and Relies on Innate Lymphoid Cells

Takashi Kadowaki, University of Tokyo, Japan
Adiponectin Receptor and Metabolic Syndrome: Pathophysiology and Therapeutic Strategy

18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)

Mizuho B
Nobuya Inagaki, Kyoto University Graduate School of Medicine, Japan

Takashi Kadowaki, University of Tokyo, Japan

Barbara B. Kahn, Beth Israel Deaconess Medical Center, Harvard Medical School, USA

Juleen R. Zierath, Karolinska Institutet, Sweden

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Mizuho A
20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Mizuho A

FRIDAY, OCTOBER 30

 
Departure


*Session Chair †Invited, not yet responded.



Keystone Symposia thanks our Lead Sponsor for generously supporting this meeting:

Takeda Pharmaceutical Company Limited
 

Keystone Symposia thanks our Sponsors for generously supporting this meeting:

Astellas Pharma Inc. Journal of Molecular Cell Biology (JMCB)
Novo Nordisk A/S Sanofi-Aventis Deutschland GmbH

We gratefully acknowledge additional support for this conference from:

Dove Medical Press Ltd Manpei Suzuki Diabetes Foundation
Otsuka Pharmaceutical Co., Ltd. The Uehara Memorial Foundation

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Assistant Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676